{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:56:25Z","timestamp":1788393385084,"version":"build-2803163510"},"reference-count":56,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["DE033887-01"],"award-info":[{"award-number":["DE033887-01"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01DE028282"],"award-info":[{"award-number":["R01DE028282"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01DE028529"],"award-info":[{"award-number":["R01DE028529"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1P50CA261605-01"],"award-info":[{"award-number":["1P50CA261605-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA28465"],"award-info":[{"award-number":["R01CA28465"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2024,12,18]]},"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Treatment with immunotherapy can elicit varying responses across cancer types, and the mechanistic underpinnings that contribute to response vrsus progression remain poorly understood. However, to date there are few preclinical models that accurately represent these disparate disease scenarios.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using combinatorial radio-immunotherapy consisting of PD-1 blockade, IL2R\u03b2\u03b3 biased signaling, and OX40 agonism we were able to generate preclinical tumor models with conflicting responses, where head and neck squamous cell carcinoma (HNSCC) models respond and pancreatic ductal adenocarcinoma (PDAC) progresses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>By modeling these disparate states, we find that regulatory T cells (Tregs) are expanded in PDAC tumors undergoing treatment, constraining tumor reactive CD8 T cell activity. Consequently, the depletion of Tregs restores the therapeutic efficacy of our treatment and abrogates the disparity between models. Moreover, we show that through heterotopic implantations the site of tumor development defines the response to therapy, as implantation of HNSCC tumors into the pancreas resulted in comparable levels of tumor progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This work highlights the complexity of combining immunotherapies within the tumor microenvironment (TME) and further defines the immune and non-immune components of the TME as an intrinsic feature of immune suppression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2024-010405","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T14:21:08Z","timestamp":1736259668000},"page":"e010405","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0560-2337","authenticated-orcid":false,"given":"Jacob","family":"Gadwa","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2778-3175","authenticated-orcid":false,"given":"Justin","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology - Head & Neck Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8458-2524","authenticated-orcid":false,"given":"Miles","family":"Piper","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5786-9837","authenticated-orcid":false,"given":"Michael W","family":"Knitz","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurel B","family":"Darragh","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Olimpo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Corbo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica I","family":"Beynor","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Neupert","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander T","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Hodgson","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diemmy","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid NM","family":"Abdelazeem","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Saviola","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurene","family":"Pousse","sequence":"additional","affiliation":[{"name":"Roche Innovation Centre Zurich, Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bransi","sequence":"additional","affiliation":[{"name":"Roche Innovation Centre Zurich, Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudita","family":"Pincha","sequence":"additional","affiliation":[{"name":"Roche Innovation Centre Zurich, Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7594-7280","authenticated-orcid":false,"given":"Christian","family":"Klein","sequence":"additional","affiliation":[{"name":"Roche Innovation Centre Zurich, Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Amann","sequence":"additional","affiliation":[{"name":"Roche Innovation Centre Zurich, Schlieren, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana D","family":"Karam","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"2025100304315284000_13.1.e010405.1","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89829","article-title":"The head and neck cancer immune landscape and its immunotherapeutic implications","volume":"1","author":"Mandal","year":"2016","journal-title":"JCI Insight"},{"key":"2025100304315284000_13.1.e010405.2","doi-asserted-by":"publisher","DOI":"10.1177\/0022034518772278"},{"key":"2025100304315284000_13.1.e010405.3","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i27.4298"},{"key":"2025100304315284000_13.1.e010405.4","unstructured":"Fares CM , Eliezer M , Van Allen M , et al . Mechanisms of resistance to immune checkpoint blockade: why does checkpoint inhibitor immunotherapy not work for all patients? In: Developmental Immunotherapy and Tumor Immunobiology. 2023."},{"key":"2025100304315284000_13.1.e010405.5","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz003"},{"key":"2025100304315284000_13.1.e010405.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00766.x"},{"key":"2025100304315284000_13.1.e010405.7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-030409-101243"},{"key":"2025100304315284000_13.1.e010405.8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nri.2017.75","article-title":"The regulation of immune tolerance by FOXP3","volume":"17","author":"Lu","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"2025100304315284000_13.1.e010405.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.06.052"},{"key":"2025100304315284000_13.1.e010405.10","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2023.100939","article-title":"OX40 agonism enhances PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum","volume":"4","author":"van der Sluis","year":"2023","journal-title":"Cell Rep Med"},{"key":"2025100304315284000_13.1.e010405.11","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-022-01265-5"},{"key":"2025100304315284000_13.1.e010405.12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.03.018"},{"key":"2025100304315284000_13.1.e010405.13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2677"},{"key":"2025100304315284000_13.1.e010405.14","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2023.101150","article-title":"Selective targeting of IL2R\u03b2\u03b3 combined with radiotherapy triggers CD8- and NK-mediated immunity, abrogating metastasis in HNSCC","volume":"4","author":"Gadwa","year":"2023","journal-title":"Cell Rep Med"},{"key":"2025100304315284000_13.1.e010405.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.04.001"},{"key":"2025100304315284000_13.1.e010405.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.12.006"},{"key":"2025100304315284000_13.1.e010405.17","doi-asserted-by":"crossref","unstructured":"Uma\u00f1a P , Deak LC , Hashimoto M . Differentiating pd-1+ stem-like cd8 t cells towards distinct effectors with enhanced therapeutic potential by an engineered il-2 cis-targeted to pd-1. In Review [Preprint]. doi:10.21203\/rs.3.rs-329812\/v1","DOI":"10.21203\/rs.3.rs-329812\/v1"},{"key":"2025100304315284000_13.1.e010405.18","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001955","article-title":"Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis","volume":"9","author":"Knitz","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2025100304315284000_13.1.e010405.19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0804308"},{"key":"2025100304315284000_13.1.e010405.20","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cancerbio-030419-033428"},{"key":"2025100304315284000_13.1.e010405.21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-01-070748"},{"key":"2025100304315284000_13.1.e010405.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.11.014"},{"key":"2025100304315284000_13.1.e010405.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01134-8"},{"key":"2025100304315284000_13.1.e010405.24","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo5558","article-title":"Acquisition of suppressive function by conventional T cells limits antitumor immunity upon Treg depletion","volume":"8","author":"Whiteside","year":"2023","journal-title":"Sci Immunol"},{"key":"2025100304315284000_13.1.e010405.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.rvsc.2022.08.026"},{"key":"2025100304315284000_13.1.e010405.26","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.034793","article-title":"Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy","volume":"11","author":"Erstad","year":"2018","journal-title":"Dis Model Mech"},{"key":"2025100304315284000_13.1.e010405.27","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2021.02.003"},{"key":"2025100304315284000_13.1.e010405.28","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031435","article-title":"KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer","volume":"8","author":"Waters","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2025100304315284000_13.1.e010405.29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature New Biol"},{"key":"2025100304315284000_13.1.e010405.30","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34676-w","article-title":"Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors","volume":"13","author":"Darragh","year":"2022","journal-title":"Nat Commun"},{"key":"2025100304315284000_13.1.e010405.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.12.022"},{"key":"2025100304315284000_13.1.e010405.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00347-z"},{"key":"2025100304315284000_13.1.e010405.33","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02701-w"},{"key":"2025100304315284000_13.1.e010405.34","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1038"},{"key":"2025100304315284000_13.1.e010405.35","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djz036"},{"key":"2025100304315284000_13.1.e010405.36","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2013.107"},{"key":"2025100304315284000_13.1.e010405.37","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0606409"},{"key":"2025100304315284000_13.1.e010405.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2012.02.009"},{"key":"2025100304315284000_13.1.e010405.39","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1158\/1078-0432.CCR-21-2767","article-title":"Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma","volume":"28","author":"Piper","year":"2022","journal-title":"Clin Cancer Res"},{"key":"2025100304315284000_13.1.e010405.40","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s43018-020-00133-0","article-title":"CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity","volume":"1","author":"Solomon","year":"2020","journal-title":"Nat Cancer"},{"key":"2025100304315284000_13.1.e010405.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.03.013"},{"key":"2025100304315284000_13.1.e010405.42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.7.1369"},{"key":"2025100304315284000_13.1.e010405.43","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61737-979-6_10"},{"key":"2025100304315284000_13.1.e010405.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.014"},{"key":"2025100304315284000_13.1.e010405.45","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0175-7"},{"key":"2025100304315284000_13.1.e010405.46","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-01080-3"},{"key":"2025100304315284000_13.1.e010405.47","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122167","article-title":"OX40L\/OX40 axis impairs follicular and natural Treg function in human SLE","volume":"3","author":"Jacquemin","year":"2018","journal-title":"JCI Insight"},{"key":"2025100304315284000_13.1.e010405.48","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071341"},{"key":"2025100304315284000_13.1.e010405.49","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900696"},{"key":"2025100304315284000_13.1.e010405.50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.6.3580"},{"key":"2025100304315284000_13.1.e010405.51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901112"},{"key":"2025100304315284000_13.1.e010405.52","doi-asserted-by":"publisher","DOI":"10.1038\/nature13954"},{"key":"2025100304315284000_13.1.e010405.53","article-title":"The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis","volume":"41","author":"Li","year":"2021","journal-title":"EClinMed"},{"key":"2025100304315284000_13.1.e010405.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.09.005"},{"key":"2025100304315284000_13.1.e010405.55","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-023-00560-y"},{"key":"2025100304315284000_13.1.e010405.56","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00574-3"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2024-010405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:32:01Z","timestamp":1759491121000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2024-010405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,7]]},"published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1136\/jitc-2024-010405"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2024-010405","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.09.06.611679","asserted-by":"object"}]},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}